Here are five details:
1. At the end of the quarter, the company recorded $2 billion in sales, a 3 percent increase year-over-year.
2. Within its knee segment, Zimmer Biomet’s sales topped $703 million, a 3.4 percent increase compared to the same quarter in 2017.
3. Zimmer Biomet’s hip segment generated $487 million in sales, a 4 percent increase year-over-year.
4. Here is Zimmer Biomet’s geographic sales breakdown:
• Americas — $1.22 billion
• EMEA — $458 million
• Asia Pacific — $334 million
5. The company’s spine business also generated $198 million in sales, a 2.5 percent increase year-over-year.
To view the full financial report, click here.
More articles on devices and implants:
CarboFix spine screw system receives FDA clearance: 3 things to know
Orthopedic devices market estimated to hit $65M by 2026: 4 key report takeaways
Implanet’s new subsidiary targets $300M market: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
